CURXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Curanex Pharmaceuticals Inc
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$4.92+0.30 (+6.49%)
Close on Oct 19, 2026
- Market cap
- $139.55M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$7.27 (−59.65%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Split
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $139.55M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 29.15
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- -$10.47M
- EPS, diluted
- -$0.38
- Book value per share
- $0.17
- Diluted shares
- 28M
Three years at a glance
Fiscal years 2023 to 2025 and trailing twelve months, USD
Operating income
-$10.55M
Net income
-$10.47M
EPS, diluted
-$0.38
Reported periodTrailing twelve months